Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,320
datasets available to search
ShareScore release 0.9.0
Dataset results
1,320 results for “Cystic fibrosis”
AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis
ClinicalTrials.gov study NCT03181932. IPD Sharing: NO. Countries: 2. Publications: 1.
A Study of the Dosing, Efficacy, and Safety of Oral Cysteamine in Adult Patients With Cystic Fibrosis Exacerbations
ClinicalTrials.gov study NCT03000348. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Long-term Safety of Lumacaftor/Ivacaftor in Participants With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation
ClinicalTrials.gov study NCT04235140. IPD Sharing: NO. Countries: 2. Publications: 2.
Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis
ClinicalTrials.gov study NCT02504827. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation
ClinicalTrials.gov study NCT00909727. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Population Pharmacokinetics and Safety of Intravenous Ceftolozane/Tazobactam in Adult Cystic Fibrosis Patients
ClinicalTrials.gov study NCT02421120. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Effects of Lumacaftor/Ivacaftor (LUM/IVA) on Exercise Tolerance in Subjects With Cystic Fibrosis (CF), Homozygous for the F508del-CFTR Mutation
ClinicalTrials.gov study NCT02875366. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa
ClinicalTrials.gov study NCT00558844. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF)
ClinicalTrials.gov study NCT02139306. IPD Sharing: NO. Countries: 16. Publications: 3.
Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis
ClinicalTrials.gov study NCT01094704. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Evaluation of VX 445/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age
ClinicalTrials.gov study NCT03691779. IPD Sharing: Not stated. Countries: 5. Publications: 3.
Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis
ClinicalTrials.gov study NCT01313624. IPD Sharing: Not stated. Countries: 3. Publications: 1.
A Study to Explore the Impact of Lumacaftor/Ivacaftor on Disease Progression in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del
ClinicalTrials.gov study NCT03625466. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Aerosolized Hypertonic Xylitol Versus Hypertonic Saline in Cystic Fibrosis (CF) Subjects
ClinicalTrials.gov study NCT00928135. IPD Sharing: Not stated. Countries: 1. Publications: 8.
Trial of Doxycycline to Reduce Sputum MMP-9 Activity in Adult Cystic Fibrosis (CF) Patients
ClinicalTrials.gov study NCT01112059. IPD Sharing: NO. Countries: 1. Publications: 1.
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
ClinicalTrials.gov study NCT02134353. IPD Sharing: Not stated. Countries: 18. Publications: 1.
Multicenter Study of Patient-reported Gastrointestinal Symptoms in People With Cystic Fibrosis
ClinicalTrials.gov study NCT03801993. IPD Sharing: NO. Countries: 1. Publications: 1.
Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis
ClinicalTrials.gov study NCT05225805. IPD Sharing: NO. Countries: 1. Publications: 1.
An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA)
ClinicalTrials.gov study NCT00787917. IPD Sharing: Not stated. Countries: 5. Publications: 1.
A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis
ClinicalTrials.gov study NCT03224351. IPD Sharing: Not stated. Countries: 4. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.